Data-Driven Prevention Initiative (DDPI)
Archived Content: This Page Is No Longer Being Updated
This page is archived for historical purposes and is no longer being maintained or updated.
Please see Overdose Data to Action (OD2A) for the most recent information on CDC-funded programs.
The Prescription Drug Overdose: Data-Driven Prevention Initiative (DDPI) awards funds to 13 states and Washington D.C. to support efforts to end the opioid overdose epidemic in the United States. This program will help states advance and evaluate their actions to address opioid misuse, abuse, and overdose. That includes increasing their ability to:
- Improve data collection and analysis around opioid misuse, abuse, and overdose;
- Develop strategies that impact behaviors driving prescription opioid dependence and abuse; and
- Work with communities to develop more comprehensive opioid overdose prevention programs.
With the over $70 million that Congress appropriated to CDC in fiscal year 2016, CDC began investing over $50 million in state health departments in support of the agency’s overarching Overdose Prevention in States (OPIS) effort to address this public health crisis. DDPI awardees beginning in 2016 are: Alabama, Alaska, Arkansas, Georgia, Hawaii, Idaho, Kansas, Louisiana, Michigan, Minnesota, Montana, New Jersey, and South Dakota, and Washington D.C.
As the opioid overdose epidemic evolves, CDC will continue to provide scientific expertise, enhance surveillance activities, and tailor resources to address states’ growing and changing needs.